Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes

  • The PLOS ONE Staff

There is an error in the title of this paper: “Glutatmatergic” should be “Glutamatergic.” The correct title is: Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutamatergic- and Insulin-Mediated Neuronal Processes.

The correct citation is: Tamási V, Petschner P, Adori C, Kirilly E, Ando RD, Tothfalusi L, et al. (2014) Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutamatergic- and Insulin-Mediated Neuronal Processes. PLoS ONE 9(11): e113662. doi:10.1371/journal.pone.0113662

Reference

  1. 1. Tamási V, Petschner P, Adori C, Kirilly E, Ando RD, Tothfalusi L, et al. (2014) Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes. PLoS ONE 9(11): e113662. pmid:25423262

Citation: The PLOS ONE Staff (2015) Correction: Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes. PLoS ONE 10(3): e0123269. https://doi.org/10.1371/journal.pone.0123269

Published: March 30, 2015

Copyright: © 2015 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited